4.8 Article

Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response

期刊

ACS NANO
卷 9, 期 6, 页码 6465-6477

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.5b02153

关键词

vaccine; polyelectrolyte multilayer; gold nanoparticle; immunology; nanotechnology; adjuvant; immunotherapy

资金

  1. NSF CAREER Award [1351688]
  2. Pharmaceutics division of the PhRMA Foundation
  3. Damon Runyon Foundation
  4. Alliance for Cancer Gene Therapy
  5. Melanoma Research Alliance
  6. NSF [DGE1322106]
  7. Div Of Chem, Bioeng, Env, & Transp Sys
  8. Directorate For Engineering [1351688] Funding Source: National Science Foundation

向作者/读者索取更多资源

Materials that allow modular, defined assembly of immune signals could support a new generation of rationally designed vaccines that promote tunable immune responses. Toward this goal, we have developed the first polyelectrolyte multilayer (PEM) coatings built entirely from immune signals. These immune-PEMs (iPEMs) are self-assembled on gold nanoparticle templates through stepwise electrostatic interactions between peptide antigen and polyanionic toll-like receptor (TLR) agonists that serve as molecular adjuvants. iPEMs do not require solvents or mixing, offer direct control over the composition and loading of vaccine components, and can be coated on substrates at any scale. These films also do not require other structural components, eliminating the potentially confounding effects caused by the inherent immune-stimulatory characteristics of many synthetic polymers. iPEM loading on gold nanoparticle substrates is tunable, and cryoTEM reveals iPEM shells coated on gold cores. These nanoparticles are efficiently internalized by primary dendritic cells (DCs), resulting in activation, selective triggering of TLR signaling, and presentation of the antigens used to assemble iPEMs. In coculture, iPEMs drive antigenspecific T cell proliferation and effector cytokines but not cytokines associated with more generalized inflammation. Compared to mice treated with soluble antigen and adjuvant, iPEM immunization promotes high levels of antigen-specific CD8(+) T cells in peripheral blood after 1 week. These enhancements result from increased DC activation and antigen presentation in draining lymph nodes. iPEM-immunized mice also exhibit a potent recall response after boosting, supporting the potential of iPEMs for designing well-defined vaccine coatings that provide high cargo density and eliminate synthetic film components.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management

Zaoqu Liu, Hui Xu, Siyuan Weng, Chunguang Guo, Qin Dang, Yuyuan Zhang, Yuqing Ren, Long Liu, Libo Wang, Xiaoyong Ge, Zhe Xing, Jian Zhang, Peng Luo, Xinwei Han

Summary: A machine learning-based prognostic signature (MLPS) has been developed to predict the prognosis of melanoma patients, showing superior predictive performance compared to clinical traits and other collected signatures.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Oncology

Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis

Tianqi Gu, Aimin Jiang, Chaozheng Zhou, Anqi Lin, Quan Cheng, Zaoqu Liu, Jian Zhang, Peng Luo

Summary: This study aims to determine the safety of immune checkpoint inhibitors combined with the anti-angiogenesis drug bevacizumab through a large-scale retrospective analysis of adverse drug reactions (ADRs). The risk of ADRs such as interstitial lung disease, hypertension, and gastrointestinal bleeding was found to be elevated in patients receiving combination therapy.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Materials Science, Multidisciplinary

Construction of antibacterial photothermal PCL/AgNPs/BP nanofibers for infected wound healing

Yanan Zhao, Yiming Liu, Chuan Tian, Zaoqu Liu, Kunpeng Wu, Chengzhi Zhang, Xinwei Han

Summary: This study constructed a nanofiber material with antibacterial and pro-angiogenic effects, which can accelerate wound healing and reduce the occurrence of infection by adding nanosilvers and black phosphorus.

MATERIALS & DESIGN (2023)

Article Engineering, Biomedical

All-in-one bioactive properties of photothermal nanofibers for accelerating diabetic wound healing

Yanan Zhao, Chuan Tian, Yiming Liu, Zaoqu Liu, Jing Li, Zijian Wang, Xinwei Han

Summary: This study presents a comprehensive strategy to remodel the harsh hypoxic microenvironment of diabetic wound healing using NIR-assisted oxygen delivery and the bioactive properties of biopolymers. The strategy involves the self-assembly of black phosphorus nanosheets and hemoglobin onto electrospun nanofibers, utilizing charged quaternized chitosan and hyaluronic acid. The composite wound dressings fabricated through this strategy showed great potential in diabetic wound healing and expanding biomedical engineering fields.

BIOMATERIALS (2023)

Review Cell Biology

Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma

Hong Luo, Hao Zhang, Jinning Mao, Hui Cao, Yihao Tao, Guanjian Zhao, Zhiwen Zhang, Nan Zhang, Zaoqu Liu, Jian Zhang, Peng Luo, Yuguo Xia, Yuan Cheng, Zongyi Xie, Quan Cheng, Guodong Liu

Summary: Exosomes play a crucial role in cell-to-cell communication by transporting DNA, RNA, bioactive proteins, glucose chains, and metabolites. They have great potential as targeted drug carriers, cancer vaccines, and noninvasive biomarkers. Being highly versatile, exosomes have advantages such as high drug loading capacity, adjustable drug release, enhanced permeation and retention effect, biodegradability, biocompatibility, and low toxicity. With the growing interest in exosome-based therapeutics, this review focuses on the potential use of exosomes in immunotherapy targeting tumor-associated macrophages (TAMs) in glioma, a challenging brain tumor. TAMs contribute to the immunosuppressive microenvironment and strongly influence glioma progression, making them an attractive therapeutic target. Exosomes can serve as both drug delivery vehicles and liquid biopsy biomarkers for TAMs-centered treatment. This review also summarizes recent investigations into the molecular signaling events by TAMs that promote glioma progression.

CELL DEATH & DISEASE (2023)

Article Oncology

Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer

Siyuan Weng, Minghao Li, Jinhai Deng, Hui Xu, Yuqing Ren, Zhaokai Zhou, Libo Wang, Yuyuan Zhang, Zhe Xing, Lifeng Li, Zaoqu Liu, Xinwei Han

Summary: This study identified and validated four molecular subtypes of gastric cancer based on the analysis of MIRcor and METcor genes, and investigated their impact on prognosis, immune microenvironment, and potential treatment.

CLINICAL EPIGENETICS (2023)

Article Immunology

Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma

Zeyu Wang, Ziyu Dai, Hao Zhang, Xisong Liang, Xun Zhang, Zhipeng Wen, Peng Luo, Jian Zhang, Zaoqu Liu, Mingyu Zhang, Quan Cheng

Summary: In this study, lactate was found to contribute to the immune suppressive microenvironment in glioblastoma through RNA sequencing and machine learning algorithms. High levels of lactate can affect the migration and infiltration of CD8 T cells in glioblastoma.

FRONTIERS IN IMMUNOLOGY (2023)

Letter Oncology

Implications of pseudogenes for the prognosis of hepatocellular carcinoma

Zaoqu Liu, Yuyuan Zhang, Siyuan Weng, Hui Xu, Xinwei Han

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Letter Oncology

Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer

Hui Xu, Zaoqu Liu, Siyuan Weng, Yuqing Ren, Jianzhuang Ren, Xinwei Han

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Article Immunology

Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer

Anqi Lin, Jiarong Yao, Quan Cheng, Zaoqu Liu, Peng Luo, Jian Zhang

Summary: This study found that the status of NOTCH pathway mutation is closely associated with the efficacy of immunotherapy in colorectal cancer (CRC) patients, and it may serve as a novel biomarker and therapeutic target for CRC.

JOURNAL OF INFLAMMATION RESEARCH (2023)

Article Oncology

Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma

Yuyuan Zhang, Zaoqu Liu, Jie Li, Xin Li, Mengjie Duo, Siyuan Weng, Peijie Lv, Guozhong Jiang, Caihong Wang, Yan Li, Shichao Liu, Zhen Li

Summary: This study explores the mutation patterns in hepatocellular carcinoma (HCC) and identifies two distinct mutation signature clusters. A high-risk prognosis cluster, MSC1, is characterized by activated anti-tumor immune and metabolism dysfunctional states, high genomic instability, and poor prognosis. Additionally, afatinib and canertinib drugs are found to have potential therapeutic implications in MSC1.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2023)

Article Medicine, General & Internal

Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

Chaozheng Zhou, Shengkun Peng, Anqi Lin, Aimin Jiang, Yuanxi Peng, Tianqi Gu, Zaoqu Liu, Quan Cheng, Jian Zhang, Peng Luo

Summary: With the increasing use of immune checkpoint inhibitors (ICIs) for tumour immunotherapy, psychiatric adverse events associated with ICIs have become a significant concern. This study aims to provide a comprehensive study and summary of psychiatric adverse events associated with ICIs.

ECLINICALMEDICINE (2023)

Review Oncology

Radiogenomics: a key component of precision cancer medicine

Zaoqu Liu, Tian Duan, Yuyuan Zhang, Siyuan Weng, Hui Xu, Yuqing Ren, Zhenyu Zhang, Xinwei Han

Summary: Radiogenomics, a field that explores the relationship between genomics and imaging phenotypes, has been widely used to address tumor heterogeneity, predict immune response and progression. It offers a lower-cost alternative to traditional genetic sequencing and provides access to whole-tumor information. By providing voxel-by-voxel genetic information, radiogenomics enables tailored therapy for heterogeneous tumors and better stratifies patients for more precise imaging and screening.

BRITISH JOURNAL OF CANCER (2023)

Review Oncology

The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control

Jinhai Deng, Teng Pan, Zaoqu Liu, Caitlin McCarthy, Jose M. Vicencio, Lulu Cao, Giovanna Alfano, Ali Abdulnabi Suwaidan, Mingzhu Yin, Richard Beatson, Tony Ng

Summary: TXNIP is a master regulator of cellular oxidation, and recent studies have revealed its additional roles in metabolism, cell cycle, and inflammation. It is extensively studied in cancers, particularly in modulating signaling between different cell types within the tumor microenvironment. Further understanding of TXNIP's functions and mechanisms in cancer may enhance its potential as a therapeutic target.

BRITISH JOURNAL OF CANCER (2023)

Review Biochemistry & Molecular Biology

Immunosenescence: molecular mechanisms and diseases

Zaoqu Liu, Qimeng Liang, Yuqing Ren, Chunguang Guo, Xiaoyong Ge, Libo Wang, Quan Cheng, Peng Luo, Yi Zhang, Xinwei Han

Summary: Aging is associated with immune dysfunction, chronic inflammation (inflammaging), and increased risk of age-related diseases. Senescent T cells and inflammaging are major drivers of immunosenescence. Investigating the role of immunosenescence in cancer and other age-related diseases is necessary.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

暂无数据